Stent insertion into the main pancreatic duct
DeviceStent insertion into the main pancreatic duct
NCT Number: NCT01673763
The presented study is designed to analyze the efficacy of pancreatic stent insertion in patients undergoing ERCP with accidental cannulation of the pancreatic duct.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Interventional
Not applicable
Deptartment of Hepatobiliary Diseases Leuven University Hospitals, Leuven, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Stent insertion into the main pancreatic duct
Time frame: up to 1 week
Technical University of Munich
Other
Study to Reduce Incidence of Post-ERCP Pancreatitis by Stent Insertion in the Main Pancreatic Duct After Unintended Cannulation of the Main Pancreatic Duct
Acronym: PEPSI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06367322
Digestive System Diseases, Pancreatic Diseases
Alicante, Spain
View Trial DetailsNCT02641561
Digestive System Diseases, Pancreatic Diseases
Camden, New Jersey, United States
View Trial DetailsNCT02308891
Digestive System Diseases, Pancreatic Diseases
Cheonan, Chungcheongnam-do, South Korea
View Trial DetailsNCT02002650
Digestive System Diseases, Pancreatic Diseases
Lanzhou, Gansu, China
View Trial Details